Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-04-25
2006-04-25
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S353000
Reexamination Certificate
active
07034026
ABSTRACT:
The present invention is directed to compounds comprising a 2,3-diphenylquinoxaline moiety which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention
REFERENCES:
patent: 4760006 (1988-07-01), Pawlowski
patent: 6060491 (2000-05-01), Pruitt et al.
patent: 0 397 859 (1990-11-01), None
patent: 1384713 (1963-11-01), None
patent: 2 293 380 (1996-03-01), None
patent: 166761 (1990-07-01), None
patent: 64-57261 (1989-01-01), None
patent: 200309578 (2000-11-01), None
patent: WO 99/42463 (1999-08-01), None
patent: WO 02/50065 (2002-06-01), None
patent: WO 03/051366 (2003-06-01), None
Hanada et al. Biochimica et Biophysica Acta, vol. 1697, p. 3-16 (2004).
Gerlicz et al., Rocz. Chem., 51:1087-1093 (1977).
Kraska et al. Pol. J. Chem., 52(9):1665-1674 (1978).
Akutsu et al., Polym. Commun., 30(6):182-183 (1989).
Akutsu et al., J. Appl. Polym. Sci., 69(9):1737-1741 (1998).
*Wang et al., Gaofenzi Tongzun, 4:300-304 (1984).
Venugopalan et al.,Indian J. Chem., 29B:364-365 (1990).
Venugopalan et al., Eur. J. Med. Chem., 24:611-614 (1989).
Chem. Abstract, vol. 63, No. 1, Abstract No. 183B, Kalle, A.G., 1965.
Nakatani et al.,J.Biol Chem., 274:21528-21532 (1999).
Shiojima and Walsh, Cir. Res., 90:1243-1250 (2002).
Bellacosa et al., Int. J. Cancer, 64:280-285 (1995).
Gilman, J. Amer. Chem. Soc., 70:2619- (1948).
Stambolic et al., Cell, 95:29-39 (1998).
Chem. Abstract, vol. III, No. 14, Abstract No. 123785c, Ishibashi, S.P., 582, 1989.
Cheng et al., Proc. Natl. Acad. Sci. U.S.A., 93:3636-3641 (1996).
Cheng et al., Proc. Natl. Acad. Sci. U.S.A., 89:9267-9271 (1992).
Downward, Curr. Opin. Cell Biol., 10:262-267 (1998).
Barnett Stanley F.
Graham Samuel L.
Remy David C.
Daniel Mark R.
Leff Matthew A.
Merck & Co. , Inc.
LandOfFree
Inhibitors of Akt activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of Akt activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of Akt activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3584830